- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results
- PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA
- PTC Therapeutics Provides Key Regulatory Updates
- PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
- PTC Therapeutics to Participate at Upcoming Investor Conferences
- PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results
More ▼
Key statistics
As of last trade, PTC Therapeutics Inc (PTCT:NSQ) traded at 25.86, 47.49% above the 52 week low of 17.53 set on Nov 02, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 25.79 |
---|---|
High | 26.00 |
Low | 25.62 |
Bid | 25.78 |
Offer | 25.90 |
Previous close | 25.41 |
Average volume | 1.09m |
---|---|
Shares outstanding | 76.61m |
Free float | 74.48m |
P/E (TTM) | -- |
Market cap | 1.95bn USD |
EPS (TTM) | -8.37 USD |
Data delayed at least 15 minutes, as of Apr 24 2024 14:58 BST.
More ▼